Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group (Q45335769)

13 December 2017

title

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group (English)

1 reference

13 December 2017

0 references

0 references

Rubins HB

1 reference

13 December 2017

Robins SJ

1 reference

13 December 2017

Collins D

1 reference

13 December 2017

Iranmanesh A

1 reference

13 December 2017

Wilt TJ

1 reference

13 December 2017

Mann D

1 reference

13 December 2017

Mayo-Smith M

1 reference

13 December 2017

Faas FH

1 reference

13 December 2017

Elam MB

1 reference

13 December 2017

Rutan GH

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

American Journal of Cardiology

13 December 2017

published in

1 reference

13 December 2017

1 reference

13 December 2017

1 reference

13 December 2017

page(s)

1196-1201

1 reference

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Prognostic importance of cholesterol levels after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-densi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Dietary reduction of serum cholesterol concentration: time to think again

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Prevalence of risk factors in men with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

The Dubbo study of the health of elderly: correlates of coronary heart disease at study entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980761-9

10.1016/S0002-9149(99)80761-9

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference